Clearmind Medicine Inc (CMND)
$1.64
Live
Performance
- $1.54$1.77$1.64
6.1%
Downside
Day's Volatility :12.99%
Upside
7.34%
- $0.13$6.80$1.64
92.37%
Downside
52 Weeks Volatility :98.16%
Upside
75.88%
Returns
| Period | Clearmind Medicine Inc | Index (Russel 2000) |
|---|---|---|
3 Months | 5.09% | 0.0% |
6 Months | 47.48% | 0.0% |
1 Year | -59.82% | 0.0% |
3 Years | -99.01% | -23.0% |
Highlights
Market Capitalization | 7.1M |
Book Value | $0.87 |
Earnings Per Share (EPS) | -1.23 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -57.95% |
Return On Equity TTM | -267.9% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -5.9M |
Diluted Eps TTM | -1.23 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Clearmind Medicine Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Clearmind Medicine Inc | 45.04% | 47.48% | -59.82% | -99.01% | -99.01% |
 Regeneron Pharmaceuticals, Inc. | -9.28% | 10.06% | 24.53% | 74.0% | 232.45% |
 Novo Nordisk A/s | -4.54% | -5.72% | 21.59% | 126.2% | 349.01% |
 Alnylam Pharmaceuticals, Inc. | 8.87% | 102.98% | 82.67% | 44.83% | 241.09% |
 Vertex Pharmaceuticals Incorporated | 5.0% | 20.77% | 31.37% | 158.16% | 163.17% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Clearmind Medicine Inc | 0.17 | NA | NA | 0.0 | -2.68 | -0.58 | NA | 0.87 |
Regeneron Pharmaceuticals, Inc. | 26.41 | 26.41 | 1.37 | 44.9 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 40.21 | 40.21 | 1.81 | 3.36 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.42 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.59 | 0.18 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Clearmind Medicine Inc | NA | $7.1M | -99.01% | 0.17 | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $110.0B | 232.45% | 26.41 | 32.04% |
Novo Nordisk A/s | Buy | $529.8B | 349.01% | 40.21 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $38.1B | 241.09% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $128.7B | 163.17% | 32.84 | -4.74% |
Insights on Clearmind Medicine Inc
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 82.9% return, outperforming this stock by 142.6%
Institutional Holdings
AdvisorShares Investments, LLC
3.18%Cornerstone Wealth Group, LLC
0.49%Geode Capital Management, LLC
0.41%Royal Bank of Canada
0.01%
Company Information
Organization | Clearmind Medicine Inc |
Employees | 0 |
CEO | Dr. Adi Zuloff-Shani Ph.D. |
Industry | Financial Conglomerates |
Discover More
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$1.64
-6.55%
Invesco Bulletshares 2025 Hi
$1.64
-6.55%
Schwab International Dividend Equity Etf
$1.64
-6.55%
Blockchain Coinvestors Acquisition Corp.
$1.64
-6.55%
Allgiant Travel Company
$1.64
-6.55%
Rogers Corp
$1.64
-6.55%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$1.64
-6.55%
Iheartmedia
$1.64
-6.55%
Lightpath Technologies Inc
$1.64
-6.55%